Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas H Keller

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Current Opinion in Chemical Biology|July 26, 2011
State of the art technologies in drug discovery 2011Alex Matter, Thomas H Keller
Pharmacological Research|January 22, 2020
Probing biological mechanisms with chemical toolsCongbao Kang, Thomas H Keller
Drug Discovery Today|April 15, 2008
Impact of non-profit organizations on drug discovery: opportunities, gaps, solutionsAlex Matter, Thomas H Keller
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
The use of porcupine inhibitors to target Wnt-driven cancersSoo Yei Ho, Thomas H Keller
Current Opinion in Chemical Biology|July 4, 2006
A practical view of 'druggability'Thomas H Keller, Arkadius Pichota, Zheng Yin
Trends in Microbiology|August 10, 2017
Zika Virus Protease: An Antiviral Drug TargetCongBao Kang, Thomas H Keller, Dahai Luo
Current Pharmaceutical Design|September 5, 2013
Drug design for flavivirus proteases: what are we missing?Anders Poulsen, Congbao Kang, Thomas H Keller
Journal of the American Chemical Society|June 30, 2010
Functionalization of peptides and proteins by Mukaiyama aldol reactionJenefer Alam, Thomas H Keller, Teck-Peng Loh
Journal of Chemical Information and Modeling|December 5, 2008
Global Bayesian models for the prioritization of antitubercular agentsPhilip Prathipati, Ngai Ling Ma, Thomas H Keller
Chemical Communications (Cambridge, England)|July 15, 2011
Indium mediated allylation in peptide and protein functionalizationJenefer Alam, Thomas H Keller, Teck-Peng Loh
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Current Opinion in Chemical Biology|July 26, 2011
State of the art technologies in drug discovery 2011Alex Matter, Thomas H Keller
Pharmacological Research|January 22, 2020
Probing biological mechanisms with chemical toolsCongbao Kang, Thomas H Keller
Drug Discovery Today|April 15, 2008
Impact of non-profit organizations on drug discovery: opportunities, gaps, solutionsAlex Matter, Thomas H Keller
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
The use of porcupine inhibitors to target Wnt-driven cancersSoo Yei Ho, Thomas H Keller
Current Opinion in Chemical Biology|July 4, 2006
A practical view of 'druggability'Thomas H Keller, Arkadius Pichota, Zheng Yin
Trends in Microbiology|August 10, 2017
Zika Virus Protease: An Antiviral Drug TargetCongBao Kang, Thomas H Keller, Dahai Luo
Current Pharmaceutical Design|September 5, 2013
Drug design for flavivirus proteases: what are we missing?Anders Poulsen, Congbao Kang, Thomas H Keller
Journal of the American Chemical Society|June 30, 2010
Functionalization of peptides and proteins by Mukaiyama aldol reactionJenefer Alam, Thomas H Keller, Teck-Peng Loh
Journal of Chemical Information and Modeling|December 5, 2008
Global Bayesian models for the prioritization of antitubercular agentsPhilip Prathipati, Ngai Ling Ma, Thomas H Keller
Chemical Communications (Cambridge, England)|July 15, 2011
Indium mediated allylation in peptide and protein functionalizationJenefer Alam, Thomas H Keller, Teck-Peng Loh
Pageof 8